Safety of TAS-102 in Patients With Metastatic Gastric/GE Junction and Colorectal Cancer
Lonsurf was well tolerated and associated with no major toxicities in two trials with 850 gastric cancer patients, said Cambridge doctor Lizzy... Read More
Johns Hopkins Researchers Design New Blood Test That Uses DNA ‘Packaging’ Patterns to Detect Multiple Cancer Types
Johns Hopkins researchers are developing a test that can detect gastric cancer from fragments of DNA in blood samples.
Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer With Peritoneal Metastases
A study following 277 gastric cancer patients with peritoneal metastases found that cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy improved overall and... Read More
Addition of docetaxel to oral fluoropyrimidine improves efficacy in patients with stage III gastric cancer
A new study suggests that adding docetaxel to fluoropyrimidine post surgery is effective in stage 3 gastric cancer.
Immuno-oncology in GI tumours: Clinical evidence and emerging trials of PD-1/PD-L1 antagonists
Scientists review the emerging trends in the use of antagonists to proteins PD-1/PD-L1 and gastrointestinal tumors.
Prognostic indicators in stage IV surgically treated gastric cancer patients: A retrospective multi-institutional study
New research looks into short- and long-term outcomes of stage four surgically treated gastric cancer patients undergoing elective surgery.
Intraperitoneal and Intravenous Paclitaxel Plus S-1 Versus Cisplatin Plus S-1
A new study shows possible clinical benefits of intraperitoneal paclitaxel for gastric cancer. Published in the Journal of Clinical Oncology, An American... Read More
Gastric cancer screening in high-risk groups cost-effective
A new modeling study in Gastroenterology shows gastric cancer screening in the US could be cost-effective in high-risk racial and ethnic groups.... Read More
Endoscopic Surveillance Detects Early Gastric Cancer
Published in Gut, researchers in the Netherlands got some interesting insight in a study using endoscopy to catch gastric cancer at an... Read More
Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial
A new study published in The Lancet finds Keytruda, the PD-1 antibody pembrolizumab, may offer a better safety profile but does not... Read More
